Aseptically Manipulated or Terminally Sterile Medicinal Products Framework (Lot 5)
key details
| Value | £80,000,000 |
|---|---|
| Status | complete |
| Category (CPV) | 33600000 +5 more |
| Region | South West |
| Deadline | 5 Jun 2023 |
| Procedure | open |
| OCID | ocds-h6vhtk-03c658 |
Awards (5)
This procurement was awarded to 5 suppliers. Values shown are per-award; the notice total is £80,000,000.
| Supplier | Value | Date | Status |
|---|---|---|---|
| Baxter Healthcare Ltd shared | · | · | active |
| Liverpool University Hospitals NHS Foundation Trust shared | · | · | active |
| Qualasept Ltd t/a Bath ASU shared | · | · | active |
| Quantum Pharmaceutical Limited shared | · | · | active |
| Sciensus Pharma Services Limited shared | · | · | active |
description
The supply of aseptically manipulated or terminally sterile products to NHS Trusts within the boundaries of the Peninsula Purchasing and Supply Alliance (PPSA). Products include national dose-banded cytotoxic and non-cytotoxic batch and patient specific medicines in ready-to-use infusion bags, pre-filled syringes & elastomeric devices.
This procurement is being managed by the PPSA on behalf of the Royal Devon University Healthcare NHS Foundation Trust acting for itself and for Gloucestershire Hospitals NHS Trust, Great Western Hospitals NHS Foundation Trust, Royal Cornwall Hospitals NHS Trust, Salisbury NHS Foundation Trust, Somerset NHS Foundation Trust, Torbay & South Devon NHS Foundation Trust, University Hospitals Plymouth NHS Trust, North Bristol NHS Trust, University Hospitals Bristol & Weston NHS Foundation Trust and the Royal United Hospital Bath NHS Foundation Trust.
notice history
4 notices published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 4 May 2023 | Contract notice (F02) | Earlier regulations | 012810-2023 |
| 18 May 2023 | Corrigendum (F14) | Earlier regulations | 014169-2023 |
| 8 Jun 2023 | Corrigendum (F14) | Earlier regulations | 016324-2023 |
| 20 Aug 2024 | Contract award notice (F03) | Earlier regulations | 026412-2024 |
more from NHS South West - Acutes
- Managed service for 3 X Renal units at North Devon, Taunton, Wellington and Bridgewater · 14 Oct 2025
- Crisis Cafes · £4,260,915 · 9 Jul 2025
- Theatre storage · 17 Jun 2025
- Provision of Compassionate Leadership Training · £60,000 · 26 Mar 2025
- Replacement of AHU at Northern Devon Hospital · 25 Feb 2025
- Replacement lift in J template · 23 Jan 2025
- Compassionate Leadership · £60,000 · 20 Jan 2025
- Primary Mental Health Treatment Requirements (MHTR) · £2,650,686 · 10 Dec 2024
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- Radiopharmaceutical Products - Poltech · The Christie NHS Foundation Trust · £39,000
- NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 · NHS England · £592,363,416
- NHS National Generics Pharmaceuticals - Supply Chain Resilience · NHS England · £52,447,296
- Generic, Branded Generic & Proprietary Medicinal Products - Group 18 · Regional Business Services Organisation, Procurement and Logistics Service · £1,800,000,000
- Generic Drugs – Injections/Infusions 2 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £6,535,850
- Transitional Drugs 7 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £53,566,932
- NP90726m Vedolizumab (Entyvio®) · The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland) · £47,898,609
- Combined Needles and Syringes Lot 1 · Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · £15,264,000
source
Published on Find a Tender. Contact details for named individuals are not reproduced on this site.